Dr. Andrew Sharabi is an Associate Professor and a member of the Head & Neck and GU Cancer Disease Teams. He is also the Director of the Center for Precision Radiation Medicine (CPRM). He is also the Director of the Moores Cancer Center Radiation Medicine Core Facility and on the Scientific Advisory Board of the San Diego Center for Precision Immunotherapy.
A dedicated Basic and Translational Scientist, his research focus is on understanding the fundamental interactions between radiation and the immune system, and on identifying strategies to combine radiation with immunotherapy. He is the Principal Investigator (PI) on a National Institutes of Health (NIH) R01 Grant focused on adaptive immune responses in Head/Neck cancer and a Co-Investigator on a prestigious NIH Moonshot U01 Grant evaluating neo-antigen T-cell responses in Head/Neck cancer. He is also the PI of a randomized phase II clinical trial translating his preclinical laboratory work into patients as well as an early phase clinical trial evaluating the safety and efficacy of combining immunotherapy and SBRT in early stage lung cancer.
In addition to being a researcher, Dr. Sharabi is also a clinician and practices at our La Jolla Facility within the Moores Cancer Center. He is involved with Resident Education overseeing the Radiation Biology Curriculum. He serves on multiple Department and National Committees including Chair of the Immunotherapy Track for the American Society for Radiation Oncology (ASTRO) Education Committee.